Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.

After grouping patients with MC in active and in remission, a highly significant difference in median FC concentrations between active MC and IBS groups ( P <0.0001) was identified ( Table 3 ), whereas median FC concentrations of patients with MC in remission did not significantly differ from patients with IBS ( Table 3 ).

also in 132,142 other papers